Discover how Viracor's CMV T Cell Immunity Panel plays a crucial role in optimizing treatment for post-transplant recipients. This video explores how the panel helps healthcare providers assess the patient's immune response to CMV medication, enabling personalized and effective treatment strategies. Understand the pivotal insights offered by Viracor's testing to enhance patient care and outcomes in CMV management.
Length of Presentation: 1 1/2 minutes
Presented by:
Eurofins Viracor